1. Progress in Clinical and Biological Research;BJ Alter,1987
2. Colbom, D., Rinehalt, J., Joseph, I., et al. (1989) ‘Expression of lymphokine-activated killer cells for clinical use utilizing a novel culture device’, J. Immunol. Methods 119, 247.
3. Epstein, M. A., Achong, B. G., Barr, Y. M., Zajac, B., Henle, G., and Henle, W. (1966) ‘Morphological and virological investigation on cultured Burkitt tumor lymphoblasts (strain Raji)’, J. Natl. Cancer Inst. 37, 549.
4. Hoyer, M., Meineke, T., Lewis, W., Zwilling, B., and Reinhart, J. (1986) ‘Characterization and modulation of human lymphokine(interleukine 2) activated killer cells induction’, Cancer Res. 46, 2834.
5. Lozzio, C. B., and Lozzio, B. B. (1973) ‘Cytotoxicity of a factor isolated from human spleen’, J. Natl. Cancer Inst. 50, 535.